Gender disparities in access to care for time-sensitive conditions during COVID-19 pandemic in Chile
Professor Advisor
dc.contributor.advisor
Pacheco, Jorge
Author
dc.contributor.author
Pacheco, Jorge
Author
dc.contributor.author
Crispi Galleguillos, María Francisca
Author
dc.contributor.author
Alfaro Morgado, Tania
Author
dc.contributor.author
Martínez Gutiérrez, María Soledad
Author
dc.contributor.author
Cuadrado Nahum, Cristóbal Alfonso
Admission date
dc.date.accessioned
2022-03-03T20:58:27Z
Available date
dc.date.available
2022-03-03T20:58:27Z
Publication date
dc.date.issued
2021
Cita de ítem
dc.identifier.citation
BMC Public Health (2021) 21:1802
es_ES
Identifier
dc.identifier.other
10.1186/s12889-021-11838-x
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/184023
Abstract
dc.description.abstract
Background During the COVID-19 pandemic, reductions in healthcare utilization are reported in different contexts. Nevertheless, studies have not explored specifically gender disparities in access to healthcare in the context of COVID-19. Methods To evaluate gender disparities in access to medical in Chile we conducted an interrupted time series analysis using segmented regression. The outcome variable was the number of weekly confirmed cases of a set of oncologic and cardiovascular time-sensitive conditions at a national level. The series contained data from weeks 1 to 39 for 2017 to 2020. The intervention period started at week 12. We selected this period because preventive interventions, such as school closures or teleworking, were implemented at this point. We estimated the level effect using a dummy variable indicating the intervention period and slope effect using a continuous variable from weeks 12 to 39. To test heterogeneity by gender and age group, we conducted a stratified analysis. Results We observed a sizable reduction in access to care with a slowly recovery for oncologic (level effect 0.323; 95% CI 0.291-0.359; slope effect 1.022; 95% CI 1.016-1.028) and cardiovascular diseases (level effect 0.586; 95% CI 0.564-0.609; slope effect 1.009; 95% CI 1.007-1.011). Greater reduction occurred in women compared to men, particularly marked on myocardial infarction (level effect 0.595; 95% CI 0.566-0.627 versus 0.532; 95% CI 0.502-0.564) and colorectal cancer (level effect 0.295; 95% CI 0.248-0.35 versus 0.19; 95% CI 0.159-0.228). Compared to men, a greater absolute reduction was observed in women for oncologic diseases, excluding sex-specific cancer, (1352; 95% CI 743-1961) and cardiovascular diseases (1268; 95% CI 946-1590). Conclusion We confirmed a large drop in new diagnoses for time-sensitive conditions during the COVID-19 pandemic in Chile. This reduction was greater for women. Our findings should alert policy-makers about the urgent need to integrate a gender perspective into the pandemic response.
es_ES
Patrocinador
dc.description.sponsorship
National Agency for Research and Development (ANID), Scholarship program, DOCTORADO BECAS CHILE 2020-21200241
COVID research fund ANID-COVID0960
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
BMC
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States